AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Qualcomm
QCOM
|
+$564M |
| 2 |
Visa
V
|
+$545M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$532M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$488M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$670M |
| 2 |
Texas Instruments
TXN
|
+$481M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$271M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$230M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$229M |
Sector Composition
| 1 | Technology | 23.44% |
| 2 | Healthcare | 14.88% |
| 3 | Consumer Discretionary | 13.29% |
| 4 | Financials | 12.61% |
| 5 | Communication Services | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
2876
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $362K | ﹤0.01% |
24,370
-8,000
| -25% | -$119K |
|
2877
Bar Harbor Bankshares
BHB
$531M
| $361K | ﹤0.01% |
12,858
+2,500
| +24% | +$70.2K |
|
2878
Kimball Electronics
KE
$735M
| $361K | ﹤0.01% |
14,000
-2,947
| -17% | -$76K |
|
|
BFS
2879
Saul Centers
BFS
$779M
| $360K | ﹤0.01% |
8,177
-670
| -8% | -$29.5K |
|
|
TRTX
2880
TPG RE Finance Trust
TRTX
$744M
| $360K | ﹤0.01% |
29,100
-2,200
| -7% | -$27.2K |
|
2881
Univest Financial
UVSP
$894M
| $359K | ﹤0.01% |
13,094
-938
| -7% | -$25.7K |
|
2882
Akero Therapeutics
AKRO
$3.46B
| $358K | ﹤0.01% |
16,000
-2,900
| -15% | -$64.9K |
|
2883
Capital Southwest
CSWC
$1.26B
| $358K | ﹤0.01% |
14,222
-6,699
| -32% | -$169K |
|
|
UBA
2884
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $358K | ﹤0.01% |
18,893
-13,762
| -42% | -$261K |
|
|
FLXN
2885
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $357K | ﹤0.01% |
58,600
| – | – |
|
2886
Ambac
AMBC
$415M
| $356K | ﹤0.01% |
24,880
-4,150
| -14% | -$59.4K |
|
2887
Harmony Biosciences
HRMY
$1.91B
| $356K | ﹤0.01% |
9,300
-5,400
| -37% | -$207K |
|
|
GRTS
2888
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $356K | ﹤0.01% |
33,000
| – | – |
|
2889
Entravision Communication
EVC
$215M
| $354K | ﹤0.01% |
49,800
-2,600
| -5% | -$18.5K |
|
2890
Koppers
KOP
$543M
| $353K | ﹤0.01% |
11,283
-2,280
| -17% | -$71.3K |
|
2891
Phathom Pharmaceuticals
PHAT
$874M
| $353K | ﹤0.01% |
11,000
-1,300
| -11% | -$41.7K |
|
2892
Carriage Services
CSV
$652M
| $352K | ﹤0.01% |
7,900
| – | – |
|
|
CURO
2893
DELISTED
CURO Group Holdings Corp.
CURO
| $352K | ﹤0.01% |
20,300
-1,500
| -7% | -$26K |
|
|
SPGS
2894
DELISTED
Simon Property Group Acquisition Holdings, Inc.
SPGS
| $351K | ﹤0.01% |
36,000
-49,473
| -58% | -$482K |
|
2895
Motorcar Parts of America
MPAA
$284M
| $350K | ﹤0.01% |
17,960
-950
| -5% | -$18.5K |
|
2896
Pathfinder Bancorp
PBHC
$92.8M
| $350K | ﹤0.01% |
+21,617
| New | +$350K |
|
2897
Hackett Group
HCKT
$563M
| $349K | ﹤0.01% |
17,797
-22,928
| -56% | -$450K |
|
|
HCCI
2898
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $349K | ﹤0.01% |
12,050
-400
| -3% | -$11.6K |
|
2899
PAVmed
PAVM
$9.29M
| $345K | ﹤0.01% |
2,693
| – | – |
|
2900
Esperion Therapeutics
ESPR
$524M
| $344K | ﹤0.01% |
28,570
| – | – |
|